Suppression of anti-CD3-induced interleukin-4 and interleukin-5 release from splenocytes of mesocestoides corti-infected BALB/c mice by phosphodiesterase 4 inhibitors

This publication has 28 references indexed in Scilit:

• Modulation of Thl- and Th2-like cytokine production from mitogen-stimulated human peripheral blood mononuclear cells by phosphodiesterase inhibitors
  General Pharmacology: The Vascular System, 1998
• Selective type IV phosphodiesterase inhibitors prevent IL‐4‐induced IgE production by human peripheral blood mononuclear cells
  Clinical and Experimental Allergy, 1997
• Evidence that cyclic AMP phosphodiesterase inhibitors suppress interleukin‐2 release from murine splenocytes by interacting with a ‘low‐affinity’ phosphodiesterase 4 conformer
  British Journal of Pharmacology, 1997
• A Novel Phosphodiesterase Inhibitor, T-440: Possible Management of Eosinophilic Inflammation by Down-Regulation of lnterleukin-5 Production
  International Archives of Allergy and Immunology, 1996
• Cytokine production by phytohemagglutinin-stimulated human blood cells: Effects of corticosteroids, T cell immunosuppressants and phosphodiesterase IV inhibitors
  Inflammation Research, 1995
• Modulation of IL-4 production in murine spleen cells by prostaglandins
  Cellular Immunology, 1995
• Effects of rolipram and CI-930 on IL-2 mRNA transcription in human Jurkat cells
  Inflammation Research, 1993
• Interleukin (IL)‐4 production by human T cells: differential regulation of IL‐4 vs. IL‐2 production
  European Journal of Immunology, 1992
• Phosphodiesterase inhibitors: new opportunities for the treatment of asthma.
  Thorax, 1991
• Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation.
  The Journal of Experimental Medicine, 1990